BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31183456)

  • 1. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
    Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
    BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
    Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
    Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
    Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham.
    Chapman C; Thomas C; Morling J; Tangri A; Oliver S; Simpson JA; Humes DJ; Banerjea A
    Colorectal Dis; 2020 Jun; 22(6):679-688. PubMed ID: 31876975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
    Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
    Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal immunochemical testing reduces demand and improves yield of Leicester's 2-week pathway for change in bowel habit.
    Khasawneh F; Osborne T; Danaher P; Barnes D; Chapman CJ; Stephenson JA; Singh B
    Colorectal Dis; 2023 Apr; 25(4):640-646. PubMed ID: 36478367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
    BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
    Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
    United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study.
    D'Souza N; Delisle TG; Chen M; Benton SC; Abulafi M;
    Br J Surg; 2021 Jul; 108(7):804-810. PubMed ID: 33755051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
    Pin Vieito N; Zarraquiños S; Cubiella J
    World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Gerrard AD; Maeda Y; Miller J; Gunn F; Theodoratou E; Noble C; Porteous L; Glancy S; MacLean P; Pattenden R; Dunlop MG; Din FVN;
    Br J Surg; 2023 Mar; 110(4):471-480. PubMed ID: 36785496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.
    Herrero JM; Vega P; Salve M; Bujanda L; Cubiella J
    BMC Gastroenterol; 2018 Oct; 18(1):155. PubMed ID: 30359225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
    Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
    Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
    D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
    Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
    Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
    Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
    Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
    Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Low' faecal immunochemical test (FIT) colorectal cancer: a 4-year comparison of the Nottingham '4F' protocol with FIT10 in symptomatic patients.
    Bailey JA; Morton AJ; Jones J; Chapman CJ; Oliver S; Morling JR; Patel H; Humes DJ; Banerjea A
    Colorectal Dis; 2024 Feb; 26(2):309-316. PubMed ID: 38173125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
    Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
    J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
    Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
    Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.